Personalized Medicine Driving Demand
The shift toward personalized medicine is a key driver for the Bioanalytical Testing Services Market. As treatments become increasingly tailored to individual patient profiles, there is a greater need for biomarker-based testing, genetic profiling, and customized pharmacokinetics analysis.
Bioanalytical service providers are integrating genomic and proteomic capabilities into their testing portfolio to support precision medicine initiatives. This alignment with patient-centric care is expected to accelerate industry growth over the coming years.
2 Views